Scientist (Pharmacology), Cardiovascular & Metabolic Diseases – NATi, A*STAR Singapore.

NATi (Nucleic Acid Therapeutics Initiative) hosts a translational engine for RNA‑based medicines, focusing on antisense oligonucleotides, siRNA, and mRNA. We seek a scientist with deep translational expertise to advance the next generation of RNA therapeutics.

We are seeking an execution‑driven, hands‑on Scientist (Pharmacology), Cardiovascular & Metabolic Diseases to support oligonucleotide discovery programs in obesity and MASH. This role is ideal for an MS‑level scientist (10+ years of experience) with strong bench depth who can own end‑to‑end in vitro cell‑based mechanistic studies and in vivo rodent PK/PD studies generating complete data packages that support pipeline programs. Prior experience in RNA/oligonucleotide programs is desired, but proven hands‑on pharmacology excellence is more important. If you can run metabolic in...